LENZ Therapeutics, Inc.
LENZ
$7.34
$0.050.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.00M | -82.13M | -58.88M | -52.40M | -47.74M |
| Total Depreciation and Amortization | 362.00K | 287.00K | 205.00K | 90.00K | 89.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.33M | 9.42M | 5.04M | 3.18M | 1.86M |
| Change in Net Operating Assets | 9.60M | 3.25M | 8.42M | 1.91M | -5.71M |
| Cash from Operations | -86.70M | -69.17M | -45.22M | -47.22M | -51.50M |
| Capital Expenditure | -735.00K | -827.00K | -938.00K | -685.00K | -578.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.66M | -74.84M | 3.22M | -54.93M | -153.01M |
| Cash from Investing | -61.40M | -75.67M | 2.28M | -55.61M | -153.59M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 149.72M | 149.75M | 27.18M | 56.42M | 29.93M |
| Repurchase of Common Stock | -- | -- | -- | -- | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -13.00K | -2.00M |
| Cash from Financing | 149.72M | 149.75M | 27.18M | 56.40M | 27.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.62M | 4.91M | -15.76M | -46.43M | -177.32M |